Yasser Hazzaa
Yasser Hazzaa is a global finance executive, founder of YH CFO Consulting, and former board director with more than 25 years of finance leadership at Bristol Myers Squibb and MannKind Corporation.
He helps biotech and life sciences teams strengthen planning, liquidity, and board reporting. He steps in quickly to close financial and operational gaps, improve runway visibility, and build reporting and controls that reduce surprises and support faster decisions as businesses scale.
With a background in electrical and software engineering, Yasser brings a practical focus on AI, analytics, and automation in finance. He has also built global finance capabilities, developed teams, and supported business transformation.
Trusted Experience Across
Primary Areas of Strategic Focus
Governance and Board Advisory
- Making strategic tradeoffs explicit through stronger board packs and decision materials.
- Institutionalizing risk governance and board-ready reporting.
- Building the discipline required for credibility and transparency with all stakeholders.
Capital Strategy and Liquidity Stewardship
- Building scenario planning and resource prioritization frameworks.
- Implementing working capital discipline and liquidity strategies.
- Designing KPI operating cadences that improve capital efficiency.
FP&A and Performance Transformation
- Transitioning organizations to driver-based forecasts that connect spending to business drivers.
- Deploying automated KPI dashboards for real-time performance visibility.
- Strengthening unit economics and profitability through targeted operational improvements.
Investor and Stakeholder Narratives
- Connecting operational results to guidance and milestones through clear executive messaging.
- Ensuring data room readiness and providing diligence support.
- Developing board-ready materials for financings, partnerships, and capital decisions.
Career highlights
Founder and Principal, YH CFO Consulting | Mar 2026 to Present
At MannKind Corporation (Nasdaq: MNKD), he served as Vice President of Finance and Treasurer from 2017 to 2025, leading FP&A, treasury, capital allocation, procurement, executive dashboards, and board materials.
At Bristol Myers Squibb, he built a 20-year track record of finance leadership across the U.S., Europe, and the Middle East, leading long-range forecasting and FP&A that supported product launches, lifecycle management, strategic partnerships, and acquisitions.
He served on the boards of TesoRx Pharma and Lipac Oncology through February 2026, providing audit and finance oversight.
Credentials
Executive MBA, International Business (with distinction), Maastricht School of Management, Netherlands, 1997.
BSc, Electrical Engineering, Ain Shams University, Cairo, Egypt, 1991.
CPA exams passed (State of Maine) and Professional Ethics exam passed (State of California).
Professional Community
Professional affiliations include FEI Los Angeles and CFO Focus (C-Suite Focus).
He has also been featured as a special guest at BioMedLey.
Yasser is a faculty member of the American Management Association.
Ready to connect?
If you need board-ready finance leadership to improve decision quality, reporting rigor, and capital discipline, let's discuss your priorities.